US Patent 12076441 Extended release amphetamine tablets
Patent 12076441 was granted and assigned to Tris Pharma on September, 2024 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 12076441 Extended release amphetamine tablets
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
